SORTILIN: Many headed hydra

Circulation Research

Volumn 116, Issue 5, 2015, Pages 764-766

  Westerterp, Marit ^a   Tall, Alan R ^a  

^a Howard Hughes Medical Institute   (United States)

Author keywords

Atherosclerosis; Editorials; Foam cells; LDL; Macrophages

Indexed keywords

CD36 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 6; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SCAVENGER RECEPTOR A; SORTILIN; VERY LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; EDITORIAL; FOAM CELL; HUMAN; LIPID STORAGE; LIPOPROTEIN SECRETION; MACROPHAGE; NONHUMAN; PINOCYTOSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SECRETORY PATHWAY; ANIMAL; AORTIC DISEASES; FEMALE; MALE; METABOLISM; PHYSIOLOGY;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; AORTIC DISEASES; ATHEROSCLEROSIS; FEMALE; FOAM CELLS; LIPOPROTEINS, LDL; MACROPHAGES; MALE;

EID: 84924365640     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.115.306036     Document Type: Editorial

References (22)

1. Kathiresan S, Melander O, Guiducci C, et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet. 2008;40:189-197. doi: 10.1038/ng.75.
2. Kathiresan S, Willer CJ, Peloso GM, et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet. 2009;41:56-65. doi: 10.1038/ng.291.
3. Musunuru K, Strong A, Frank-Kamenetsky M, et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature. 2010;466:714-719. doi: 10.1038/nature09266.
4. Strong A, Ding Q, Edmondson AC, et al. Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism. J Clin Invest. 2012;122:2807-2816. doi: 10.1172/JCI63563.
5. Ai D, Baez JM, Jiang H, Conlon DM, Hernandez-Ono A, Frank-Kamenetsky M, Milstein S, Fitzgerald K, Murphy AJ, Woo CW, Strong A, Ginsberg HN, Tabas I, Rader DJ, Tall AR. Activation of ER stress and mTORC1 suppresses hepatic sortilin-1 levels in obese mice. J Clin Invest. 2012;122:1677-1687. doi: 10.1172/JCI61248.
6. Bi L, Chiang JY, Ding WX, Dunn W, Roberts B, Li T. Saturated fatty acids activate ERK signaling to downregulate hepatic sortilin 1 in obese and diabetic mice. J Lipid Res. 2013;54:2754-2762. doi: 10.1194/jlr.M039347.
7. Mortensen MB, Kjolby M, Gunnersen S, Larsen JV, Palmfeldt J, Falk E, Nykjaer A, Bentzon JF. Targeting sortilin in immune cells reduces proinflammatory cytokines and atherosclerosis. J Clin Invest. 2014;124:5317-5322. doi: 10.1172/JCI76002.
8. Patel KM, Strong A, Tohyama J, Jin X, Morales CR, Billheimer J, Millar JS, Kruth H, Rader DJ. Macrophage sortilin promotes LDL uptake, foam cell formation, and atherosclerosis. Circ Res. 2015;116:789-796. doi: 10.1161/CIRCRESAHA.116.305811.
9. Quistgaard EM, Madsen P, Grøftehauge MK, Nissen P, Petersen CM, Thirup SS. Ligands bind to Sortilin in the tunnel of a ten-bladed beta-propeller domain. Nat Struct Mol Biol. 2009;16:96-98. doi: 10.1038/nsmb.1543.
10. Nielsen MS, Jacobsen C, Olivecrona G, Gliemann J, Petersen CM. Sortilin/neurotensin receptor-3 binds and mediates degradation of lipoprotein lipase. J Biol Chem. 1999;274:8832-8836.
11. Nilsson SK, Christensen S, Raarup MK, Ryan RO, Nielsen MS, Olivecrona G. Endocytosis of apolipoprotein A-V by members of the low density lipoprotein receptor and the VPS10p domain receptor families. J Biol Chem. 2008;283:25920-25927. doi: 10.1074/jbc.M802721200.
12. Babaev VR, Fazio S, Gleaves LA, Carter KJ, Semenkovich CF, Linton MF. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo. J Clin Invest. 1999;103:1697-1705. doi: 10.1172/JCI6117.
13. Manning-Tobin JJ, Moore KJ, Seimon TA, Bell SA, Sharuk M, Alvarez-Leite JI, de Winther MP, Tabas I, Freeman MW. Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice. Arterioscler Thromb Vasc Biol. 2009;29:19-26. doi: 10.1161/ATVBAHA.108.176644.
14. Moore KJ, Kunjathoor VV, Koehn SL, Manning JJ, Tseng AA, Silver JM, McKee M, Freeman MW. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. J Clin Invest. 2005;115:2192-2201. doi: 10.1172/JCI24061.
15. Herijgers N, Van Eck M, Groot PH, Hoogerbrugge PM, Van Berkel TJ. Effect of bone marrow transplantation on lipoprotein metabolism and atherosclerosis in LDL receptor-knockout mice. Arterioscler Thromb Vasc Biol. 1997;17:1995-2003.
16. Linsel-Nitschke P, Heeren J, Aherrahrou Z, et al. Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease. Atherosclerosis. 2010;208:183-189. doi: 10.1016/j.atherosclerosis.2009.06.034.
17. Gustafsen C, Kjolby M, Nyegaard M, Mattheisen M, Lundhede J, Buttenschøn H, Mors O, Bentzon JF, Madsen P, Nykjaer A, Glerup S. The hypercholesterolemia-risk gene SORT1 facilitates PCSK9 secretion. Cell Metab. 2014;19:310-318. doi: 10.1016/j.cmet.2013.12.006.
18. Strong A, Patel K, Rader DJ. Sortilin and lipoprotein metabolism: making sense out of complexity. Curr Opin Lipidol. 2014;25:350-357. doi: 10.1097/MOL.0000000000000110.
19. Tall AR, Ai D. Sorting out sortilin. Circ Res. 2011;108:158-160. doi: 10.1161/RES.0b013e31820d7daa.
20. Willnow TE, Kjølby M, Nykjaer A. Sortilins: new players in lipoprotein metabolism. Curr Opin Lipidol. 2011;22:79-85. doi: 10.1097/MOL.0b013e3283416f2b.
21. Strong A, Rader DJ. Sortilin as a regulator of lipoprotein metabolism. Curr Atheroscler Rep. 2012;14:211-218. doi: 10.1007/s11883-012-0248-x.
22. Kjolby M, Andersen OM, Breiderhoff T, Fjorback AW, Pedersen KM, Madsen P, Jansen P, Heeren J, Willnow TE, Nykjaer A. Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export. Cell Metab. 2010;12:213-223. doi: 10.1016/j.cmet.2010.08.006.